Found: 58
Select item for more details and to access through your institution.
Androgen receptor expression predicts beneficial tamoxifen response in oestrogen receptor-α-negative breast cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
GATA3 and markers of epithelial-mesenchymal transition predict long-term benefit from tamoxifen in ER-positive breast cancer.
- Published in:
- NPJ Breast Cancer, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41523-024-00688-6
- By:
- Publication type:
- Article
Interrelations of clinicopathologic variables and their prognostic value in colorectal adenocarcinoma.
- Published in:
- APMIS, 1996, v. 104, n. 1-6, p. 35, doi. 10.1111/j.1699-0463.1996.tb00683.x
- By:
- Publication type:
- Article
c-erbB-2 oncoprotein in relation to DNA ploidy and prognosis in colorectal adenocarcinoma.
- Published in:
- APMIS, 1995, v. 103, n. 1-6, p. 309, doi. 10.1111/j.1699-0463.1995.tb01112.x
- By:
- Publication type:
- Article
Hypoxia inducible factor-1α is a prognostic marker in premenopausal patients with intermediate to highly differentiated breast cancer but not a predictive marker for tamoxifen response.
- Published in:
- International Journal of Cancer, 2006, v. 118, n. 10, p. 2609, doi. 10.1002/ijc.21676
- By:
- Publication type:
- Article
Glutathione S-transferase T1 and M1 genotypes in normal mucosa, transitional mucosa and colorectal adenocarcinoma.
- Published in:
- International Journal of Cancer, 1999, v. 84, n. 2, p. 135, doi. 10.1002/(SICI)1097-0215(19990420)84:2<135::AID-IJC7>3.0.CO;2-C
- By:
- Publication type:
- Article
Determination of glucocorticoid receptors in leukemic myeloblasts by isoelectric focusing in polyacrylamide gel.
- Published in:
- American Journal of Hematology, 1985, v. 20, n. 4, p. 383, doi. 10.1002/ajh.2830200410
- By:
- Publication type:
- Article
Adjuvant Chemotherapy With Sequential or Concurrent Anthracycline and Docetaxel: Breast International Group 02-98 Randomized Trial.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2008, v. 100, n. 2, p. 121, doi. 10.1 093/i nci/djm287
- By:
- Publication type:
- Article
Coronary Heart Disease Mortality After 5 Years of Adjuvant Tamoxifen Therapy: Results from a Randomized Trial.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2005, v. 97, n. 21, p. 1609, doi. 10.1093/jnci/dji342
- By:
- Publication type:
- Article
Amplification of HSD17B1 and ERBB2 in primary breast cancer.
- Published in:
- Oncogene, 2003, v. 22, n. 1, p. 34, doi. 10.1038/sj.onc.1206078
- By:
- Publication type:
- Article
Heat shock protein 72/73 in relation to cytoplasmic p53 expression and prognosis in colorectal adenocarcinomas.
- Published in:
- International Journal of Cancer, 1997, v. 74, n. 6, p. 600, doi. 10.1002/(SICI)1097-0215(19971219)74:6<600::AID-IJC7>3.0.CO;2-Y
- By:
- Publication type:
- Article
Proliferating cell nuclear antigen (PCNA) in relation to ras, c-erbB-2, p53, clinico-pathological variables and prognosis in colorectal adenocarcinoma.
- Published in:
- International Journal of Cancer, 1996, v. 69, n. 1, p. 5, doi. 10.1002/(SICI)1097-0215(19960220)69:1<5::AID-IJC2>3.0.CO;2-8
- By:
- Publication type:
- Article
S-phase fraction after gating on epithelial cells predicts recurrence in node-negative breast cancer.
- Published in:
- International Journal of Cancer, 1994, v. 59, n. 1, p. 7, doi. 10.1002/ijc.2910590103
- By:
- Publication type:
- Article
Relationships of DNA ploidy, S-phase fraction and hormone receptor status to tumor stage in breast cancers detected by population screening.
- Published in:
- International Journal of Cancer, 1992, v. 51, n. 1, p. 28, doi. 10.1002/ijc.2910510106
- By:
- Publication type:
- Article
Estrogen receptor concentrations in 269 cases of histologically classified human breast cancer.
- Published in:
- 1980
- By:
- Publication type:
- journal article
Raptor localization predicts prognosis and tamoxifen response in estrogen receptor-positive breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 168, n. 1, p. 17, doi. 10.1007/s10549-017-4508-x
- By:
- Publication type:
- Article
Tamoxifen therapy benefit for patients with 70-gene signature high and low risk.
- Published in:
- Breast Cancer Research & Treatment, 2017, v. 166, n. 2, p. 593, doi. 10.1007/s10549-017-4428-9
- By:
- Publication type:
- Article
Loss of protein tyrosine phosphatase, non-receptor type 2 is associated with activation of AKT and tamoxifen resistance in breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 153, n. 1, p. 31, doi. 10.1007/s10549-015-3516-y
- By:
- Publication type:
- Article
Lack of G protein-coupled estrogen receptor (GPER) in the plasma membrane is associated with excellent long-term prognosis in breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2014, v. 145, n. 1, p. 61, doi. 10.1007/s10549-014-2936-4
- By:
- Publication type:
- Article
C-X-C ligand 10 and C-X-C receptor 3 status can predict tamoxifen treatment response in breast cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2014, v. 145, n. 1, p. 73, doi. 10.1007/s10549-014-2933-7
- By:
- Publication type:
- Article
Intratumor Heterogeneity of the Estrogen Receptor and the Long-term Risk of Fatal Breast Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
RAB6C is an independent prognostic factor of estrogen receptor-positive/progesterone receptor-negative breast cancer.
- Published in:
- Oncology Letters, 2020, v. 19, n. 1, p. 52, doi. 10.3892/ol.2019.11109
- By:
- Publication type:
- Article
Polyoma virus replication in ascitic cells.
- Published in:
- International Journal of Cancer, 1968, v. 3, n. 5, p. 628, doi. 10.1002/ijc.2910030511
- By:
- Publication type:
- Article
Interactions between Chemotherapy, Endocrine Therapy and Radiation.
- Published in:
- Acta Oncologica, 2002, v. 41, n. 7/8, p. 635, doi. 10.1080/028418602321028247
- By:
- Publication type:
- Article
Swedish Cancer Society Radiation Therapy Research Investigation.
- Published in:
- Acta Oncologica, 2002, v. 41, n. 7/8, p. 596, doi. 10.1080/028418602321028193
- By:
- Publication type:
- Article
P53 Expression and the Result of Adjuvant Therapy of Breast Cancer.
- Published in:
- Acta Oncologica, 1995, v. 34, n. 6, p. 767, doi. 10.3109/02841869509127184
- By:
- Publication type:
- Article
Adenoid cystic carcinoma: Significance of DNA ploidy.
- Published in:
- Head & Neck, 1995, v. 17, n. 4, p. 319, doi. 10.1002/hed.2880170408
- By:
- Publication type:
- Article
Heterogeneity of salivary gland tumors studied by flow cytometry.
- Published in:
- Head & Neck, 1993, v. 15, n. 6, p. 514, doi. 10.1002/hed.2880150607
- By:
- Publication type:
- Article
The effects of PTPN2 loss on cell signalling and clinical outcome in relation to breast cancer subtype.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2019, v. 145, n. 7, p. 1845, doi. 10.1007/s00432-019-02918-y
- By:
- Publication type:
- Article
PTPN2 deficiency along with activation of nuclear Akt predict endocrine resistance in breast cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2019, v. 145, n. 3, p. 599, doi. 10.1007/s00432-018-2810-6
- By:
- Publication type:
- Article
Long-term effects on the incidence of second primary cancers in a randomized trial of two and five years of adjuvant tamoxifen.
- Published in:
- Acta Oncologica, 2017, v. 56, n. 4, p. 614, doi. 10.1080/0284186X.2016.1273547
- By:
- Publication type:
- Article
Bisphosphonate treatment in primary breast cancer: Results from a randomised comparison of oral pamidronate versus no pamidronate in patients with primary breast cancer.
- Published in:
- Acta Oncologica, 2008, v. 47, n. 4, p. 740, doi. 10.1080/02841860801964988
- By:
- Publication type:
- Article
Mutation and Accumulation of p53 Related to Results of Adjuvant Therapy of Postmenopausal Breast Cancer Patients.
- Published in:
- Acta Oncologica, 2004, v. 43, n. 3, p. 235, doi. 10.1080/02841860410029474
- By:
- Publication type:
- Article
Tamoxifen-predictive value of gene expression signatures in premenopausal breast cancer: data from the randomized SBII:2 trial.
- Published in:
- Breast Cancer Research, 2023, v. 25, n. 1, p. 1, doi. 10.1186/s13058-023-01719-z
- By:
- Publication type:
- Article
Tumour-infiltrating lymphocytes as a prognostic and tamoxifen predictive marker in premenopausal breast cancer: data from a randomised trial with long-term follow-up.
- Published in:
- 2020
- By:
- Publication type:
- journal article
17β-Hydroxysteroid Dehydrogenase Type 14 Is a Predictive Marker for Tamoxifen Response in Oestrogen Receptor Positive Breast Cancer.
- Published in:
- PLoS ONE, 2012, v. 7, n. 7, p. 1, doi. 10.1371/journal.pone.0040568
- By:
- Publication type:
- Article
MCM3 upregulation confers endocrine resistance in breast cancer and is a predictive marker of diminished tamoxifen benefit.
- Published in:
- NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-020-00210-8
- By:
- Publication type:
- Article
MEMBRANE IMMUNOFLUORESCENCE ON CULTURED INDICATOR CELLS AS A MEASURE OF VIRUS PRODUCTION BY MOUSE L CELLS AND BY TWO MOLONEY LYMPHOMA SUBLINES DIFFERING IN IMMUNOSENSITIVITY*.
- Published in:
- Annals of the New York Academy of Sciences, 1971, v. 177, n. 1, p. 121, doi. 10.1111/j.1749-6632.1971.tb35038.x
- By:
- Publication type:
- Article
The mTOR effectors 4EBP1 and S6K2 are frequently coexpressed, and associated with a poor prognosis and endocrine resistance in breast cancer: a retrospective study including patients from the randomised Stockholm tamoxifen trials.
- Published in:
- Breast Cancer Research, 2013, v. 15, n. 5, p. 2, doi. 10.1186/bcr3557
- By:
- Publication type:
- Article
The mTOR effectors 4EBP1 and S6K2 are frequently coexpressed, and associated with a poor prognosis and endocrine resistance in breast cancer: a retrospective study including patients from the randomised Stockholm tamoxifen trials.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Effects of adjuvant tamoxifen therapy on cardiac disease: results from a randomized trial with long-term follow-up.
- Published in:
- Breast Cancer Research & Treatment, 2013, v. 138, n. 2, p. 467, doi. 10.1007/s10549-013-2457-6
- By:
- Publication type:
- Article
Activation of Akt, mTOR, and the estrogen receptor as a signature to predict tamoxifen treatment benefit.
- Published in:
- Breast Cancer Research & Treatment, 2013, v. 137, n. 2, p. 397, doi. 10.1007/s10549-012-2376-y
- By:
- Publication type:
- Article
Clinical potential of the mTOR targets S6K1 and S6K2 in breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2011, v. 128, n. 3, p. 713, doi. 10.1007/s10549-010-1058-x
- By:
- Publication type:
- Article
Immunohistochemistry compared to cytosol assays for determination of estrogen receptor and prediction of the long-term effect of adjuvant tamoxifen.
- Published in:
- Breast Cancer Research & Treatment, 2011, v. 126, n. 2, p. 421, doi. 10.1007/s10549-010-1202-7
- By:
- Publication type:
- Article
The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial.
- Published in:
- Breast Cancer Research & Treatment, 2010, v. 119, n. 1, p. 145, doi. 10.1007/s10549-009-0512-0
- By:
- Publication type:
- Article
In situ levels of oestrogen producing enzymes and its prognostic significance in postmenopausal breast cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2008, v. 112, n. 1, p. 15
- By:
- Publication type:
- Article
HER2 status in hormone receptor positive premenopausal primary breast cancer adds prognostic, but not tamoxifen treatment predictive, information.
- Published in:
- Breast Cancer Research & Treatment, 2008, v. 109, n. 2, p. 351, doi. 10.1007/s10549-007-9660-2
- By:
- Publication type:
- Article
Exploring the two-gene ratio in breast cancer-independent roles for HOXB13 and IL17BR in prediction of clinical outcome.
- Published in:
- Breast Cancer Research & Treatment, 2008, v. 107, n. 2, p. 225, doi. 10.1007/s10549-007-9541-8
- By:
- Publication type:
- Article
Amplification of HSD17B1 has prognostic significance in postmenopausal breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2008, v. 108, n. 1, p. 35, doi. 10.1007/s10549-007-9579-7
- By:
- Publication type:
- Article
Role of cyclin D1 in ErbB2-positive breast cancer and tamoxifen resistance.
- Published in:
- Breast Cancer Research & Treatment, 2005, v. 91, n. 2, p. 145, doi. 10.1007/s10549-004-6457-4
- By:
- Publication type:
- Article